Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 2

Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease

Pages
116–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

LDL, UA, VFA, and REE can be used as good evaluation indicators.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The high prevalence and incidence of non-alcoholic fatty liver disease (NAFLD) have become a global medical concern.
📊
Key Findings & Data:Methods: All the enrolled NAFLD patients were divided into 2 groups: the obese group (205 patients with body mass index (BMI) ≥ 25 kg/m2) and the lean group (73 patients with BMI < 25 kg/m2).
💡
Conclusion & Impact:LDL, UA, VFA, and REE can be used as good evaluation indicators.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background: The high prevalence and incidence of non-alcoholic fatty liver disease (NAFLD) have become a global medical concern. Compared with obesity, metabolic abnormalities may be more critical. Currently, there is lack of relevant data for nutritional status and energy metabolic characteristics in patients with obese and lean NAFLD. Methods: All the enrolled NAFLD patients were divided into 2 groups: the obese group (205 patients with body mass index (BMI) ≥ 25 kg/m2) and the lean group (73 patients with BMI < 25 kg/m2). Using a body composition analyzer, we analyzed their nutritional status including skeletal muscle, body fat, protein content, and visceral fat area (VFA). Energy metabolic characteristics including resting energy expenditure (REE), respiratory quotient, and oxidation rate of 3 major nutrients (carbohydrate, CHO%, fat, FAT%, and protein, PRO%) were analyzed by metabolic cart. Results: The lean NAFLD patients’ LDL-c and UA even increased significantly than the obese patients (P = .001 and .006, respectively). Compared with the control group, VFA and REE were significantly higher in the lean NAFLD group (P = .008, P < .001 respectively). CHO%, FAT%, and PRO% in the lean NAFLD group were 29.31 ± 7.07%, 55.59 ± 12.09%, and 15.10 ± 4.07%, respectively, and there was no significant difference compared to the control. However, compared to the obese NAFLD group, their CHO% increased, whereas FAT% decreased (both P < .001). Conclusion: NAFLD patients suffer from nutritional imbalances and energy metabolic abnormalities, regardless of whether they are associated with obesity. LDL, UA, VFA, and REE can be used as good evaluation indicators.

🔖

Cite This Article

YE, Q., YAN, J., XIAO, H., HAN, T. (2021). Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 2, 116–122. https://ajindex.com/articles/408868

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Younossi Z, Tacke F, Arrese M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019
  2. 69(6):2672-2682. [CrossRef] 2. Kaya E, Yılmaz Y. Non-alcoholic fatty liver disease: a growing public health problem in Turkey. Turk J Gastroenterol. 2019
  3. 30(10):865- 871. [CrossRef] 3. Zhou F, Zhou J, Wang W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019
  4. 70(4):1119-1133. [CrossRef] 4. Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. 2016
  5. 17(5):774. [CrossRef] 5. Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017
  6. 9(16):715-732. [CrossRef] 6. Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017
  7. 67(4):862-873. [CrossRef] 7. Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020
  8. 5(8):739-752. [CrossRef] 8. Wang AY, Dhaliwal J, Mouzaki M. Lean non-alcoholic fatty liver disease. Clin Nutr. 2019
  9. 38(3):975-981. [CrossRef] 9. Niklas J, Bonin A, Mangin S, et al. Central energy metabolism remains robust in acute steatotic hepatocytes challenged by a high free fatty acid load. BMB Rep. 2012
  10. 45(7):396-401. [CrossRef] 10. Yılmaz Y, Kanı HT, Demirtaş CÖ, et al. Growing burden of nonalcoholic fatty liver disease in Turkey: a single-center experience. Turk J Gastroenterol. 2019
  11. 30(10):892-898. [CrossRef] 11. National Institute of Health (NIH). BMI classifications for underweight, normal weight, overweight and obese. https://ww w.nhl bi.ni h.gov /heal th/ed ucati onal/ lose_ wt/BM I/bmi dis. htm. 12. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004
  12. 363(9403):157-163. [CrossRef] 13. Jian-gao F, Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Zhonghua Gan Zang Bing Za Zhi. 2010
  13. 18(3):163-166. 14. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. 1949. Nutrition. 1990
  14. 6(3):213- 221. [CrossRef] 15. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus